Floatz logo

Sinecatechins

Prostatic Hyperplasia

H. Lee Moffitt Cancer Center and Research InstitutemixturePhase 2Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
36/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Prostatic Hyperplasia cohort.

Asset / SponsorPhaseRating
DINITROGEN MONOXIDE
Beth Israel Deaconess Medical Center
Phase 4BB
AVOLVE
Turku University Hospital
Phase 4BB
TESTOSTERONE UNDECYLATE
University of Florence
Phase 4BB
Oxygen
Beth Israel Deaconess Medical Center
Phase 4BB
DICLOFENAC
Taha Uçar
Phase 4BB

View all 17 →

Same molecule, other indications

Sinecatechins is also rated in:

nicotine dependenceDormant
CCC
Indicative ·
51 / 100
View asset →
colorectal adenomaDormant
CCC
Indicative ·
48 / 100
View asset →
ductal breast carcinoma in situDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →